Currently Funded EGRP Grants
Previously Funded EGRP Grants
Grant Status | Currently Funded |
Division | Division of Cancer Control and Population Sciences |
Program | Epidemiology and Genomics Research Program (EGRP) |
Topic | DNA Specimens |
Showing 1 to 25 of 177 entries
PI Name | Organization Name | Project Title (Click for Abstract, Pubs, etc.) | Grant Number | Awarded Dollars | Fiscal Year |
---|---|---|---|---|---|
Afshar-Kharghan, Vahid | University of TX MD Anderson Can Ctr | Genetics of Graft-Versus-Host Disease | 5R01CA231141-05 | $240,692 | 2022 |
Akinyemiju, Tomi F | Duke University | Systemic Racism and Biological Embodiment of Risk in Breast Cancer Mortality | 5R01CA263770-02 | $788,797 | 2023 |
Aldrich, Melinda | Vanderbilt University Medical Center | Understanding Determinants of Racial Disparities in Lung Cancer Incidence | 5U01CA253560-04 | $240,995 | 2023 |
Aldrich, Melinda | Vanderbilt University Medical Center | Incorporating Residential Histories Into Assessment of Cancer Risk in a Predominantly Low-Income and Racially Diverse Population | 1R01CA276266-01A1 | $601,879 | 2023 |
Ambrosone, Christine B. | Roswell Park Cancer Institute Corp | Relationships Between Parity, Breastfeeding and Er Breast Cancer in African American Women: Elucidating the Biologic Underpinnings at the Molecular and Cellular Level. | 5R01CA225947-05 | $592,214 | 2023 |
Ambrosone, Christine B. | Roswell Park Cancer Institute Corp | Tumor Immune Contexture and Breast Cancer Disparities: a Multi-Disciplinary Study in Women of African and European Ancestry | 5R01CA247281-04 | $1,112,696 | 2023 |
Amos, Christopher I. | Baylor College of Medicine | Integrative Analysis of Lung Cancer Etiology and Risk | 2U19CA203654-07 | $2,910,518 | 2023 |
Anderson, Garnet L. | Fred Hutchinson Cancer Center | Life and Longevity After Cancer (LILAC): the Women's Health Initiative Cancer Survivor Cohort | 5U01CA173642-11 | $1,308,977 | 2023 |
Asgari, Maryam Mandana | University of Colorado Denver | Pq3 Cutaneous Squamous Cell Carcinoma: Integrating Germline and Somatic Alterations That Underlie Tumor Progression | 7R01CA231264-05 | $374,307 | 2023 |
Baughn, Linda B | Mayo Clinic Rochester | Differences in Tumor Biology of Multiple Myeloma in Association with African Ancestry | 1R37CA272883-01A1 | $431,708 | 2023 |
Belinsky, Steven A | Lovelace Biomedical Research Institute | DNA Repair Capacity Assays for Lung Disease Risk Assessment | 5U01CA232505-06 | $806,066 | 2022 |
Berger, Michael F. | Sloan-Kettering Inst Can Research | (PQ3) Integrative Biomarkers of Cancer Progression and Therapeutic Response From Germline and Somatic Clinical Sequencing | 5R01CA227534-05 | $697,766 | 2023 |
Berwick, Marianne | University of New Mexico Health Scis Ctr | Integration of Clinical and Molecular Biomarkers for Melanoma Survival | 5P01CA206980-06 | $598,220 | 2022 |
Bhatia, Smita | University of Alabama at Birmingham | Bmt Survivor Study-2 (Bmtss-2) | 5U01CA213140-05 | $1,266,852 | 2023 |
Binder, Alexandra Margaret Lynn | University of Hawaii at Manoa | Characterizing the Risk of Chemotherapy Side Effects Based on Epigenetic Age and Modification By Resistance Training Intervention | 5R37CA263064-03 | $636,830 | 2023 |
Bondy, Melissa L. | Stanford University | Discovery, Biology and Risk of Inherited Variants in Glioma | 5R01CA217105-05 | $829,381 | 2023 |
Bondy, Melissa L. | Stanford University | Characterizing Germline and Somatic Alterations By Glioma Subtypes and Clinical Outcome | 5R01CA232754-05 | $923,381 | 2023 |
Bradbury, Angela R. | University of Pennsylvania | RESPECT3: a Randomized Type 1 Hybrid Effectiveness-Implementation Study of Returning Actionable Genetic Panel Research Results | 5R01CA190871-08 | $737,730 | 2023 |
Brash, Douglas E | Yale University | Using Clonal and Non-Clonal Uv Signature Mutations to Predict Skin Cancer Risk | 5R01CA240602-05 | $357,871 | 2023 |
Brown, Elizabeth E | University of Alabama at Birmingham | Epigenetic Contribution to the Excess Risk of Mgus in African Americans | 5U01CA249955-03 | $596,783 | 2023 |
Brown, Jennifer R | Dana-Farber Cancer Inst | Genetic Predisposition to Chronic Lymphocytic Leukemia (CLL) | 5R01CA258924-03 | $668,037 | 2023 |
Burch, James | Virginia Commonwealth University | Role of Circadian Factors in Inflammation and Colorectal Adenoma Risk | 5R01CA231321-05 | $597,997 | 2022 |
Burch, James | Virginia Commonwealth University | Role of Circadian Factors in Inflammation and Colorectal Adenoma Risk | 3R01CA231321-05S1 | $74,664 | 2022 |
Buring, Julie E. | Brigham and Women's Hospital | Women's Health Study: Infrastructure Support for Cohort Follow-Up | 5U01CA182913-10 | $629,372 | 2023 |
Burk, Robert D | Albert Einstein College of Medicine | Investigations Into the Molecular Pathogenesis of Cervical Glandular Neoplasias | 5U01CA238592-04 | $571,572 | 2023 |